HelioLiver LDT now available to order through Quest Diagnostics
Business team celebrating an award win
News & Media

Helio Genomics Recognized as Healthcare Technology of the Year

Award Oct 8, 2022 5 min read IMA IMPACT Awards
Share

Helio Genomics was recognized by the Internet Marketing Association (IMA) as Healthcare Technology of the Year at its annual IMPACT Awards.

IMA IMPACT Awards
IMA IMPACT Awards
2022 Winner

Helio Genomics was recognized by the Internet Marketing Association (IMA) as Healthcare Technology of the Year at their annual IMPACT Awards.

The IMPACT Awards exemplify best-in-class creativity, expertise and results achieved by the top practitioners of Internet marketing, innovation and leadership across every business segment.

See the full list of award winners at impact22.live/awards.

Read the Full Article

Recognition awarded at the 2022 IMA IMPACT Awards. View all winners.

Related Articles

More from Helio Genomics

NewsMay 12, 2026

HelioLiver Expands Access Through Quest

Helio broadens access to HelioLiver through Quest Diagnostics’ nationwide network of patient service centers.

Read more
NewsMay 8, 2026

Collaborating with the Rural Health Transformation Collaborative, Co-Chaired by Microsoft

Helio joins the Rural Health Transformation Collaborative, co-chaired by Microsoft, to expand rural early detection.

Read more
VoicesMay 6, 2026

Bharat Tewarie: Giving Patients a “Real Fighting Chance” Against Liver Cancer

Helio’s CEO reflects on the landmark CLiMB study and what earlier liver cancer detection means for patients.

Read more